SNTI - Senti Biosciences, Inc.

1.01
-0.130   -12.871%

Share volume: 262,125
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.21%

PREVIOUS CLOSE
CHG
CHG%
$1.14
-0.13
-0.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
39%
Profitability 35%
Dept financing 37%
Liquidity 58%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-11.40%
1 Month
17.26%
3 Months
-3.81%
6 Months
-51.44%
1 Year
-79.26%
2 Year
259.56%
Key data
Stock price
$1.01
P/E Ratio 
N/A
DAY RANGE
$1.00 - $1.13
EPS 
-$2.87
52 WEEK RANGE
$0.77 - $4.95
52 WEEK CHANGE
-$79.80
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
31.144 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
3.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$304,567
AVERAGE 30 VOLUME 
$182,616
Company detail
CEO: Timothy K. Lu
Region: US
Website: sentibio.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Dynamics Special Purpose Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination. The company was incorporated in 2021 and is based in Redwood City, California.

Recent news